BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.530
0.00 (0.00%)
At close: Jun 2, 2026, 4:00 PM EDT
3.650
+0.120 (3.40%)
After-hours: Jun 2, 2026, 6:40 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $5.85 million as of June 2, 2026. Its market cap has decreased by -74.98% in one year.
Market Cap
5.85M
Enterprise Value
9.98M
1-Year Change
-74.98%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $9.78B to $5.85M, a decrease of -99.94%. That is a compound annual growth rate of -74.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 5.85M | -82.55% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardio Diagnostics Holdings | 6.30M |
| Aptevo Therapeutics | 6.19M |
| SciSparc | 6.07M |
| FibroBiologics | 6.05M |
| XTL Biopharmaceuticals | 6.04M |
| Bio Green Med Solution | 5.91M |
| Mustang Bio | 5.83M |
| CollPlant Biotechnologies | 5.78M |